Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-078110
Filing Date
2010-08-16
Accepted
2010-08-16 17:10:17
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g24376e10vq.htm 10-Q 172667
2 EX-10.7 g24376exv10w7.htm EX-10.7 198797
3 EX-31.1 g24376exv31w1.htm EX-31.1 7582
4 EX-31.2 g24376exv31w2.htm EX-31.2 7619
5 EX-32.1 g24376exv32w1.htm EX-32.1 3957
  Complete submission text file 0000950123-10-078110.txt   392008
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 101020879
SIC: 2834 Pharmaceutical Preparations